Page last updated: 2024-10-31

nabumetone and Angiogenesis, Pathologic

nabumetone has been researched along with Angiogenesis, Pathologic in 1 studies

Nabumetone: A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.
nabumetone : A methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs.

Research Excerpts

ExcerptRelevanceReference
"To evaluate photodynamic therapy (PDT) combined with the preferential the cyclooxygenase-2 (COX-2) inhibitor, nabumetone in the treatment of the neovascular age-related macular degeneration (ARMD)."9.19Progression of macular atrophy after PDT combined with the COX-2 inhibitor Nabumetone in the treatment of neovascular ARMD. ( Chrapek, O; Karhanova, M; Langova, K; Pracharova, Z; Rehak, J; Sin, M, 2014)
"To evaluate photodynamic therapy (PDT) combined with the preferential the cyclooxygenase-2 (COX-2) inhibitor, nabumetone in the treatment of the neovascular age-related macular degeneration (ARMD)."5.19Progression of macular atrophy after PDT combined with the COX-2 inhibitor Nabumetone in the treatment of neovascular ARMD. ( Chrapek, O; Karhanova, M; Langova, K; Pracharova, Z; Rehak, J; Sin, M, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sin, M1
Chrapek, O1
Karhanova, M1
Pracharova, Z1
Langova, K1
Rehak, J1

Trials

1 trial available for nabumetone and Angiogenesis, Pathologic

ArticleYear
Progression of macular atrophy after PDT combined with the COX-2 inhibitor Nabumetone in the treatment of neovascular ARMD.
    Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2014, Volume: 158, Issue:1

    Topics: Aged; Aged, 80 and over; Atrophy; Butanones; Choroid; Cyclooxygenase 2 Inhibitors; Disease Progressi

2014